These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23720150)

  • 1. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
    Golan T; Urban D; Berger R; Lawrence YR
    Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based assessment of the surgical management of locally advanced colorectal cancer.
    Govindarajan A; Coburn NG; Kiss A; Rabeneck L; Smith AJ; Law CH
    J Natl Cancer Inst; 2006 Oct; 98(20):1474-81. PubMed ID: 17047196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
    Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
    J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
    Cummings LC; Payes JD; Cooper GS
    Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
    Worni M; Guller U; White RR; Castleberry AW; Pietrobon R; Cerny T; Gloor B; Koeberle D
    Pancreas; 2013 Oct; 42(7):1157-63. PubMed ID: 23867367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.
    Coburn NG; Govindarajan A; Law CH; Guller U; Kiss A; Ringash J; Swallow CJ; Baxter NN
    Ann Surg Oncol; 2008 Feb; 15(2):500-7. PubMed ID: 18026800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting survival for well-differentiated liposarcoma: the importance of tumor location.
    Smith CA; Martinez SR; Tseng WH; Tamurian RM; Bold RJ; Borys D; Canter RJ
    J Surg Res; 2012 Jun; 175(1):12-7. PubMed ID: 21920555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
    Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
    Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does young age influence the prognosis of colorectal cancer: a population-based analysis.
    McKay A; Donaleshen J; Helewa RM; Park J; Wirtzfeld D; Hochman D; Singh H; Turner D
    World J Surg Oncol; 2014 Dec; 12():370. PubMed ID: 25466394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis.
    Renouf DJ; Lim HJ; Speers C; Villa D; Gill S; Blanke CD; O'Reilly SE; Kennecke H
    Clin Colorectal Cancer; 2011 Jun; 10(2):97-101. PubMed ID: 21859560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.
    Brunner AM; Campigotto F; Sadrzadeh H; Drapkin BJ; Chen YB; Neuberg DS; Fathi AT
    Cancer; 2013 Jul; 119(14):2620-9. PubMed ID: 23625575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
    Coburn NG; Swallow CJ; Kiss A; Law C
    Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic factors in colorectal carcinoma.
    Deliu IC; Georgescu EF; Bezna MC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):808-16. PubMed ID: 25341305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognostic features in adult pineoblastomas: analysis of cases from the SEER database.
    Selvanathan SK; Hammouche S; Smethurst W; Salminen HJ; Jenkinson MD
    Acta Neurochir (Wien); 2012 May; 154(5):863-9. PubMed ID: 22460262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
    Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
    J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.